Blueprint Medicines Corpo... (BPMC)
NASDAQ: BPMC
· Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM
Blueprint Medicines Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 562.12M | 508.82M | 434.41M | 362.8M | 282.21M | 249.38M | 216.2M | 225.62M | 204.59M | 204.04M | 272.28M | 230.49M | 221.24M | 180.08M | 107.17M | 828.1M | 809.14M |
Cost of Revenue | 23.39M | 28.59M | 22.93M | 25.55M | 16.67M | 11.84M | 14.9M | 13.35M | 15.91M | 17.81M | 20.51M | 21.3M | 22.91M | 17.93M | 10.51M | 6.87M | 503K |
Gross Profit | 538.73M | 480.23M | 411.48M | 337.24M | 265.54M | 237.54M | 201.31M | 212.27M | 188.68M | 186.22M | 251.76M | 209.18M | 198.32M | 162.15M | 96.65M | 821.23M | 808.64M |
Operating Income | -174.31M | -212.04M | -275.95M | -355.96M | -440.89M | -497.45M | -549.15M | -544.45M | -574.11M | -544.53M | -703.77M | -696.59M | -647.46M | -641.9M | -411.81M | 338.65M | 322.13M |
Interest Income | 31.48M | 40.66M | 40.1M | 38.28M | 36.09M | 32.81M | 22.98M | 16.6M | 9.28M | 3.83M | 5.47M | 2.52M | 2.72M | 3.02M | 2.31M | 3.48M | 2.85M |
Pretax Income | -153.89M | -65.86M | -127.44M | -204.95M | -287.66M | -506.02M | -552.76M | -551.52M | -575.5M | -552.27M | -710.72M | -695.51M | -647.18M | -641.08M | -410.01M | 341.4M | 326.18M |
Net Income | -155.73M | -67.09M | -128.05M | -205.49M | -288.29M | -506.98M | -554.71M | -554.15M | -581.07M | -557.51M | -717.56M | -701.64M | -650.37M | -644.09M | -411.07M | 340.15M | 325.12M |
Selling & General & Admin | 371.52M | 359.27M | 342.09M | 322.91M | 305.5M | 292.89M | 277.64M | 264.51M | 251.26M | 237.37M | 227.55M | 219.75M | 210.35M | 195.29M | 183.63M | 171.2M | 164.09M |
Research & Development | 341.51M | 333.01M | 345.34M | 370.29M | 399.7M | 428.39M | 450.23M | 467.96M | 486.36M | 477.42M | 716.46M | 672.89M | 624.46M | 601.03M | 321.56M | 311.37M | 322.42M |
Other Expenses | -1K | 375K | -202K | -930K | -929K | -9K | 2.44M | 4.83M | 6.98M | 8.95M | 6.69M | 4.51M | 1.99M | -1.49M | -1.06M | -729K | -379K |
Operating Expenses | 713.04M | 692.28M | 687.43M | 693.2M | 706.43M | 723.82M | 732.27M | 738.53M | 744.6M | 723.74M | 955.62M | 905.86M | 845.87M | 804.13M | 508.46M | 482.58M | 486.52M |
Interest Expense | 45.6M | 68.81M | 65.64M | 60.01M | 54.96M | 51.6M | 60.9M | 59.1M | 47.37M | 35.65M | 11.35M | 6K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 79.67M | 96.6M | 83.28M | 69.61M | 65.62M | 58.74M | 59.94M | 54.59M | 35.87M | 25.82M | 21.22M | 13.5M | 13.5M | 13.5M | 6.89M | 6.89M | 6.89M |
Cost & Expenses | 736.43M | 720.87M | 710.37M | 718.75M | 723.1M | 735.66M | 747.17M | 751.88M | 760.51M | 741.55M | 976.13M | 927.16M | 868.78M | 822.06M | 518.98M | 489.44M | 487.02M |
Income Tax Expense | 1.84M | 1.23M | 616K | 540K | 628K | 968K | 1.94M | 2.63M | 5.57M | 5.24M | 6.83M | 6.12M | 3.19M | 2.27M | 318K | 513K | 320K |
Shares Outstanding (Basic) | 63.6M | 63.6M | 63.38M | 62.85M | 61.58M | 60.89M | 60.69M | 60.52M | 60.13M | 59.87M | 59.71M | 59.62M | 59.31M | 58.98M | 58.62M | 58.41M | 58.02M |
Shares Outstanding (Diluted) | 63.6M | 63.6M | 63.38M | 62.85M | 63.8M | 60.89M | 60.69M | 60.52M | 60.13M | 59.87M | 59.76M | 59.62M | 59.31M | 58.98M | 58.65M | 58.41M | 58.02M |
EPS (Basic) | -2.47 | -1.03 | -2.06 | -3.37 | -4.76 | -8.36 | -9.19 | -9.22 | -9.71 | -9.35 | -12.1 | -11.87 | -11.05 | -10.98 | -7.11 | 6.38 | 5.96 |
EPS (Diluted) | -2.47 | -1.08 | -2.11 | -3.42 | -4.81 | -8.36 | -9.19 | -9.22 | -9.71 | -9.35 | -12.1 | -11.87 | -11.05 | -10.98 | -7.11 | 6.05 | 5.63 |
EBITDA | -131.05M | -163.98M | -240.44M | -322.27M | -407.82M | -445.24M | -480.86M | -485.81M | -525.89M | -516.6M | -690.16M | -683.86M | -635.67M | -632.15M | -403.7M | 345.17M | 328.72M |
EBIT | -108.29M | 2.94M | -89.4M | -172.54M | -260.31M | -482.02M | -506.49M | -509.99M | -545.7M | -534.2M | -697.87M | -691.06M | -643M | -637.42M | -411.78M | 339.63M | 323.11M |
Depreciation & Amortization | -22.76M | 16.29M | 13.82M | 15.13M | 17.35M | 18.42M | 26.06M | 24.61M | 22.32M | 20.1M | 14.23M | 13.72M | 13.32M | 12.79M | 11.16M | 9.59M | 8.12M |